Raia Drogasil S.A. - ADR
RADLY
Get informed when a big investor buys or sells
+ FollowMarket Cap$7.22B
Close$
$1.09
73.7% downside
Current Fair Value
73.7% downsideOvervalued by 73.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $7.22 Billion |
|---|---|
| Enterprise Value | $15.42 Billion |
| Dividend Yield | $0.08 (2.10%) |
| Earnings per Share | $0.77 |
| Beta | 0.01 |
| Outstanding Shares | 1,748,536,237 |
Return
| Return on Equity | 18.64% |
|---|---|
| Return on Assets | 5.41% |
| Return on Invested Capital | 18.77% |
Valuation & Multiples
| P/E Ratio | 27.64 |
|---|---|
| PEG | 171.79 |
| Price to Sales | 0.17 |
| Price to Book Ratio | 1.03 |
| Enterprise Value to Revenue | 0.34 |
| Enterprise Value to EBIT | 5.49 |
| Enterprise Value to Net Income | 11 |
| Total Debt to Enterprise | 0.57 |
| Debt to Equity | 1.2 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
October 7, 2026
EPS Estimate
$0.05
Average shareholder expectationRevenue Estimate
$2.21 B
Average shareholder expectationNext Earnings Call
Expected Date
November 3, 2026
EPS Estimate
$0.05
Average shareholder expectationRevenue Estimate
$2.41 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Raia Drogasil S.A.
75,594 employees
CEO: Renato Raduan Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics and specialty medicines in Brazil. The company sells its products through stores, telesales, and call ...